Proteins are amazing molecules that play critical roles in building and repairing bodies, protecting against diseases, and are essential in humans, plants, and animals. The realized value of proteins is on the rise across applications including medical, food and beverage, nutrition, and beauty. Historically, industries have relied on animals as the source of proteins for commercial use, posing significant challenges in the areas of performance, sustainability, ethics, and quality.
GELTOR, the leader in biodesigned proteins, utilizes its proprietary biodesign platform to unlock new opportunities and create solutions with innovative, sustainable, and highly effective protein products.
“Geltor delivers the power of biology through fermentation with performance and scale that is essential for customers like global food and beauty brands. Our first product was a collagen that could never be isolated from an animal, it can only be made through biotechnology. Year after year we continue building our biodesign platform to grow and help more markets and customers.” says Alex Lorestani, CEO and co-founder of GELTOR.
Innovative Biodesign Platform Achieves Better Outcomes, Faster
GELTOR has emerged as a leader in biotechnology by developing a unique and sustainable biodesign platform that rapidly delivers best-in-class protein products at commercial scale. The need for a reliable biodesign solution for global businesses has fueled Geltor’s growth. Using their flexible biodesign platform, the team translates product concepts into a scalable product within months. Historically, new protein development required years of developments and heavy capital investments.
The company has curated a portfolio of protein solutions for beauty and wellness customers. Today, a Geltor-powered product is purchased by a consumer every 3 seconds. Geltor’s portfolio includes unique biomimetic proteins that match rare, high-performing amino acid sequences found in nature like human Type 21 collagen, human elastin, marine and animal collagens. Biomimetic proteins capture and optimize the benefit found in nature, without depleting resources or using animal inputs.
As CTO and co-founder of GELTOR, Nick Ouzounov, PhD says, “We had to develop everything in-house. We can design from end-to-end, and now we have achieved industrial scale, reaching millions of liters of fermentation and a 100% success rate of every manufacturing round so far. That is unheard of in the biotech space.”
The fermentation platform provides a precise and sustainable approach to biomanufacturing proteins. The highly controlled process and renewable plant-based inputs yield a finished product with unparalleled purity, consistency, and quality.
Overcoming grand challenges for society
GELTOR has set forth a new pace within the biotech industry by tackling major sustainability challenges that many markets face today. Sustainability remains at the forefront of many consumers’ buying decisions, encompassing environmental, human, and animal impacts.
“The traditional method of acquiring a protein is environmentally damaging. We are reaching the limits as to what we can and want to extract from animals. We needed to find a more sustainable way of not only making proteins but making better proteins. Biodesign can empower a cleaner, better product for humans and our planet.” said Dr. Ouzounov.
Biotechnology offers a sustainable alternative to a reliance on natural resources. A life cycle analysis performed in 2020 revealed biodesigned collagen utilizes substantially less land and water than animal-derived collagen and produces half the CO2 emissions.
GELTOR continues to grow in the beauty and wellness space, while expanding into new markets. New innovations in the pipeline will help many industries meet the evolving needs of consumers, while making a positive impact on the planet.
